Skip to main content
Equibles

BARCLAYS PLC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$529,045
+$385,099 QoQ
Shares Held
36,893
+138.9% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 158 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. ZVRA ranks #160 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in ZVRA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $529,045 36,893
2026-03-31 $143,946 15,445
2025-12-31 $897,209 100,135
2025-09-30 $3,161,532 332,443
2025-06-30 $919,331 104,351
2025-03-31 $3,255,828 434,690
2024-12-31 $2,415,997 289,688
2024-09-30 $399,737 57,599
2024-06-30 $71,897 14,673
2024-03-31 $148,514 25,606
2023-12-31 $327,480 49,997
2023-09-30 $28,751 5,965
2023-06-30 $35,373 6,936
2023-03-31 $599 109
2022-12-31 $1,620 353
2022-09-30 $10,339 1,657